Article
Outcome Measures for Clinical Trials of Leber Congenital Amaurosis Caused by the Intronic Mutation in the CEP290 Gene.
Investigative ophthalmology & visual science - 1 May 2017
Jacobson Samuel G, Cideciyan Artur V, Sumaroka Alexander, Roman Alejandro J, Charng Jason, Lu Monica, Choi Windy, Sheplock Rebecca, Swider Malgorzata, Kosyk Mychajlo S, Schwartz Sharon B, Stone Edwin M, Fishman Gerald A
Abstract excerpt
Purpose: To determine efficacy outcome measures for clinical trials of Leber congenital amaurosis (LCA) associated with a common intronic mutation in the CEP290 gene. Methods: CEP290-LCA patients (ages 5-48) with the intronic mutation (c.2991+1655A>G) were studied as a retrospective observational case series using clinical methods and with full-field sensitivity testing (FST), optical coherence tomography (OCT),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
